ResearcherPeking University First HospitalActive in the last 2 years

Yuxin Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5126892618. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

SGLT2 inhibition induces autophagic flux blockade and sensitizes pancreatic cancer to EGFR-targeted therapy. Co-author DOI 10.1007/s13402-026-01256-9 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Enkui Zhang · 1 shared paper, 2026 · strength 0.30
- Paper SGLT2 inhibition induces autophagic flux blockade and sensitizes pancreatic cancer to EGFR-targeted therapy. DOI 10.1007/s13402-026-01256-9 ↗
Yongsu Ma · 1 shared paper, 2026 · strength 0.30
- Paper SGLT2 inhibition induces autophagic flux blockade and sensitizes pancreatic cancer to EGFR-targeted therapy. DOI 10.1007/s13402-026-01256-9 ↗
Xiaodong Tian · 1 shared paper, 2026 · strength 0.30
- Paper SGLT2 inhibition induces autophagic flux blockade and sensitizes pancreatic cancer to EGFR-targeted therapy. DOI 10.1007/s13402-026-01256-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.